Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by Khersonon Nov 26, 2015 9:20am
119 Views
Post# 24327512

RE:RE:Another Poseidon Concepts?

RE:RE:Another Poseidon Concepts?
Kherson wrote:
Where Valeant has gone wrong today is that their ad hoc Special Committee should not have been made up of any Board members, but outside independent investigators. In reality, all Valeant is now doing is kicking the can down the road and trying to buy time.
Folks can say what they want, even Mr. Donville, but the shorters have indeed uncovered something that is material.
Kherson

I posted the above one month ago today! David Milstead of the Globe and Mail has penned a great article today covering my exact concerns about Valeant's review process!
Kherson

<< Previous
Bullboard Posts
Next >>